Patents by Inventor Kirsten SCHNEIDER-OHRUM

Kirsten SCHNEIDER-OHRUM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMMUNOTHERAPEUTIC COMPOSITIONS
    Publication number: 20230022956
    Abstract: The present disclosure provides compositions and methods useful for treating Glioblastoma Multiforme (GBM) which comprise virus-like particles (VLPs) comprising murine leukemia virus (MLV) core proteins and the human cytomegalovirus epitopes, gB and pp65, formulated with an adjuvant comprising a saponin and a TLR4 agonist.
    Type: Application
    Filed: September 8, 2022
    Publication date: January 26, 2023
    Applicants: GLAXOSMITHKLINE BIOLOGICALS SA, VARIATION BIOTECHNOLOGIES INC.
    Inventors: Kirsten SCHNEIDER-OHRUM, David Evander ANDERSON
  • IMMUNOTHERAPEUTIC COMPOSITIONS
    Publication number: 20210069321
    Abstract: The present disclosure provides compositions and methods useful for treating Glioblastoma Multiforme (GBM) which comprise virus-like particles (VLPs) comprising murine leukemia virus (MLV) core proteins and the human cytomegalovirus epitopes, gB and pp65, formulated with an adjuvant comprising a saponin and a TLR4 agonist.
    Type: Application
    Filed: September 8, 2020
    Publication date: March 11, 2021
    Applicants: GLAXOSMITHKLINE BIOLOGICALS SA, VARIATION BIOTECHNOLOGIES INC.
    Inventors: Kirsten SCHNEIDER-OHRUM, David Evander ANDERSON